Butyrolactones from Aspergillus terreus

Chemical and Pharmaceutical Bulletin

Volumn 48, Issue 4, 2000, Pages 559-562

  Rao, K V ^a   Sadhukhan, A K ^a   Veerender, M ^a   Ravikumar, V ^a   Mohan, E V S ^a   Dhanvantri, S D ^a   Sitaramkumar, M ^a   Moses Babu, J ^a   Vyas, K ^a   Om Reddy, G ^a  

^a DR REDDY S RESEARCH FOUNDATION   (India)

Author keywords

Aspergillus terreus; Biological activity; Butyrolactone; Solid state fermentation

Indexed keywords

ANTIINFECTIVE AGENT; BUTYROLACTONE 4; CYTOTOXIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; ASPERGILLUS TERREUS; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; NONHUMAN; STEREOCHEMISTRY; X RAY CRYSTALLOGRAPHY;

EID: 0034015918     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.48.559     Document Type: Article

References (7)

1. Sadhukhan A. K., Ramana Murthy M. V., Ganesh Reddy D., Rao K. V., Venkataramana K., Venkateswarlu A., Indian Patent., 96/MDS/786 (1996).
2. Fujii I., Ebizuka Y., Sankawa U., Chem. Pharm. Bull., 30, 2283-2286 (1982).
3. Kiriyama N., Nitta K., Sakaguchi Y., Taguchi Y., Yamamoto Y., Chem. Pharm. Bull., 25, 2593-2601 (1977).
4. 13C-NMR data have not been reported previously.
5. Altomare A., Cascarano M., Giacovazzo C., Guagliardi A., J. Appl. Cryst., 26, 343 (1993).
6. Molecular Structure Corporation. (1995). TEXSAN. Single Crystal Structure Analysis Software. Version 1.7. MSC, 3200 Research Forest Drive, The Woodlands, TX 77381, U.S.A.
7. Anne M., Dominic S., Philip S., Robert R., Kenneth P., David V., Curtis H., John L., Paul C., Vaigro-Wolff A., Gray-Goodrich M., Campbell H., Joseph M., Boyd M., J. Natl. Cancer Inst., 83, 757-776 (1991).